RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2023 - $891,364
2022 - $1,199,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Amounts flagged (*) below are 50% funded by Cancer League of Colorado and 50% matched by MDC/RICHMOND AMERICAN HOMES FOUNDATION.
Swati G. Patel, MD, MS
Identification of Hereditary Cancer Syndromes through Advanced Polyps
$ 30,000
2020
Molishree Joshi, PhD
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
$ 30,000
2020
Matthew Tallaferro, PhD
Control of cell division through centrosomal RNA localization
$ 30,000
2020
Diana M. Cittelly, PhD
Function of Ephrin B Signaling in Breast cancer brain metastasis
$ 30,000
2020
Rebecca Schweppe, PhD
The role of Nuclear FAK in Thyroid Cancer
$ 30,000
2020
Maureen Lynch, Phd & Philip Owens, PhD
The role of exercise in breast cancer bone metastasis
$ 60,000
2020
Christine Towers, PhD
Identifying novel regulators of mitochondrial turn over
$ 30,000
2020
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
$ 60,000
2020
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
The role of alpha-1 antitrypsin in cancer immunotherapy
$ 60,000
2020
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
$ 60,000
2020
Heather Brechbuhl, PhD
Defining reversible tumor traits in the obese microenvironment
$ 30,000
2019
Carol Sartorius, PhD
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
$ 30,000
2019
Cem Altunbas, PhD
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
$ 30,000
2019
Isabel Schlaepfer, PhD
Role of fat oxidation via CPT1A in immunological response to prostate cancer
$ 30,000
2019
Paul Norman, PhD
Natural Killer cells can protect from developing leukemia
$ 30,000
2019
Zachary Levi Watson, PhD
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
$ 30,000
2019
John Tentler, PhD
Cancer Research Summer Fellowship Program
$ 30,000
2019
Adam Mueller, MD, PhD
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
$ 30,000
2019
Jay Hesselberth, PhD
Single-cell methods to measure functional heterogeneity
$ 30,000
2019
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
$ 60,000
2019
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
$ 60,000
2019
Yiqun Shellman, PhD & Martin McCarter, MD
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
$ 60,000
2019
Mayumi Fujita, MD, PhD & Donald Backos, PhD
Somatic mutations in inflammasome genes in melanoma
$ 60,000
2019
Neil Box, PhD
Regulation of p53 in tanning
$ 30,000
2019
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
$ 60,000
2019
Rajeev Vibhakar, MD, PhD, MPH
Role of CDK7 in medulloblastoma
$ 30,000
2019
Stephen Keysar, PhD
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
$ 30,000
2019
Matthew Sikora, PhD
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
$ 30,000
2019
Jennifer DeLuca, PhD
Targeting Kinetochore Dysfunction in Cancer Cells
$ 30,000
2018
David Thomas, PhD and Mark Borden, PhD
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy
$ 30,000
2018
Maria Jose Contreras, PhD
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
$ 30,000
2018
Nathan Dahl, MD
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
$ 30,000
2018
Adwitiya Kar, PhD and Margaret Wierman, MD
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
$ 30,000
2018
Courtney Jones, PhD
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
$ 30,000
2018
Mair E.A. Churchill, PhD
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
$ 30,000
2018
Jessica Lake, MD, MPH
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
$ 30,000
2018
Jill Slansky PhD
Functional activation of low-affinity T cells in the tumor
$ 30,000
2018
Raul M. Torres, PhD
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
$ 30,000
2018
Christopher Lieu, MD and Todd Pitts, MD
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
$ 60,000
2018
Linda Van Dyk, PhD
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
$ 30,000
2018
Benjamin Bitler, PhD
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
$ 30,000
2018
Jennifer Hintzsche, PhD
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
$ 30,000
2018
Martin McCarter, MD
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
$ 30,000
2018
David Ryan Ormond MD
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
$ 30,000
2018
Zhangguo Chen, PhD
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
$ 30,000
2018
John Tentler, PhD
Cancer Research Summer Fellowship Program
$ 30,000
2018
Rebecca Schweppe, PhD
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
$ 30,000
2018
Scott Cramer, PhD and James Costello, PhD
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
$ 60,000
2018
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
$ 60,000
2018
Nicholas Forman, MD
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
$ 30,000
2018
Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD
Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics
60,000
2017
Jung-Jae Lee, PhD
Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer
29,835
2017
Darinee Tippimanchai, PhD
Targeting IL17 in Kras mutant lung cancer
30,000
2017
Jenna Sopfe, MD
Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population
29,961
2017
John Tentler, PhD
Cancer Research Summer Fellowship Program
30,000
2017
Rebecca Schweppe, PhD
Targeting FAK and Src in Thyroid Cancer
30,000
2017
Matthew J. Sikora, PhD
Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma
30,000
2017
Jing H. Wang, MD, PhD
Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses
30,000
2017
Kasey Couts, PhD
Improving targeted therapy in melanomas with BRAF fusions
30,000
2017
Britta Jacobsen, PhD
Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer
30,000
2017
Eric Clambey, PhD
High-dimensional analysis of effector T cell mechanisms in lung cancer
30,000
2017
Heide L. Ford, PhD
Role of Six2 in mediating late stage metastasis
30,000
2017
Paul Jedlicka, MD, PhD
The epigenetic modifiers PHF2 and PhF8 in Ewing Sarcoma
30,000
2017
Changwei Liu, PhD
Validating USP35 as an anticancer drug target
30,000
2017
Hyunmin Kim, PhD
Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer
30,000
2017
David Bentley, PhD
Deregulation of mRNA 3′ end formation in breast cancer
30,000
2017
Dan Theodorescu, MD, PhD
Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients
30,000
2017
Todd Hankinson, MD, MBA
Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression
27,976
2017
Sana Karam, MD, PhD
Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer
30,000
2017
Amanda C. Winters, MD, PhD
Validating CD123 as a Leukemia Stem Cell Marker and Therapeutic Target in Pediatric AML
30,000
2017
James Costello, PhD
Measuring chromosome-conformation abnormalities within a single cancer cell
30,000
2017
Traci R. Lyons, PhD and Beth Taburini, PhD
Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity
60,000
2017
James DeGregori, PhD
Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer
30,000
2017
Isabel Schlaepfer, PhD
Role of androgens on lipid catabolism in prostate cancer
30,000
2016
Scott Alper, PhD and Daniel Pollyea, MD, MS
Splicing gene mutations and infection in MDS patients
30,000
2016